kaplan-meier survival estimates bias version 11.06 (Verlag GmbH)
90
Structured Review
Verlag GmbH
kaplan-meier survival estimates bias version 11.06
Kaplan Meier Survival Estimates Bias Version 11.06, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kaplan-meier+survival+estimates+bias+version+11%2E06/kaplan+meier+survival+estimates+bias+version+11+06/pm32960329-75-27-30
Average 90 stars, based on 1 article reviews
Kaplan Meier Survival Estimates Bias Version 11.06, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/kaplan-meier+survival+estimates+bias+version+11%2E06/kaplan+meier+survival+estimates+bias+version+11+06/pm32960329-75-27-30
Average 90 stars, based on 1 article reviews
kaplan-meier survival estimates bias version 11.06 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial. Article Snippet: Objectives To prospectively evaluate the therapy response of third-line TACE with DSM or lipiodol in the treatment of CRLM using MRI.. Methods In this prospective, randomized, single-center trial, patients were randomly assigned to receive TACE therapy with either lipiodol or DSM as the embolization agent.. Therapy response was evaluated using MRI. |